Skip to main content
Erschienen in: Journal of Infection and Chemotherapy 3/2012

01.06.2012 | Original Article

A case study of measles vaccination for university students during the measles outbreak in Tokyo, Japan, 2007

verfasst von: Ryuichi Fujisaki, Mariko Yamamura, Shigeru Abe, Kousuke Shimogawara, Michihiro Kasahara, Hajime Nishiya, Miho Makimura, Koichi Makimura

Erschienen in: Journal of Infection and Chemotherapy | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

In April 2007, seven students belonging to the same class at Teikyo University developed measles. To prevent the spread of infection, 27 of 106 students in the same class who had low anti-measles antibody titers as measured by hemagglutination inhibition (HI) assay were vaccinated. After the outbreak had subsided, the HI values were investigated in 103 students, and they answered questionnaires about their health condition during the period of the outbreak and their previous clinical histories of measles, including vaccination records. There was no new case of measles after introduction of the vaccination program. However, the HI titers of 42% of the students who were not vaccinated in this program were significantly elevated. Fever and catarrhal signs occurred in 7 of these students with pre-exposure titers of 8 or less. The post-exposure HI titers of 71% of students who were unaffected by measles and had high HI titers (>8) before the epidemic did not increase. These results suggested that people with low HI titers may become potential carriers of measles and that measurement of pre-exposure HI anti-measles antibody titer is a useful method for selection of candidates to undergo vaccination.
Literatur
1.
Zurück zum Zitat Griffin DE. Measles virus. In: Knipe DM, Howley PM, editors. Fields virology. 4th edn. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1401–41. Griffin DE. Measles virus. In: Knipe DM, Howley PM, editors. Fields virology. 4th edn. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1401–41.
2.
Zurück zum Zitat World Health Organization. Progress in reducing global measles death: 1999–2004. Wkly Epidemiol Rec. 2006;81:90–4. World Health Organization. Progress in reducing global measles death: 1999–2004. Wkly Epidemiol Rec. 2006;81:90–4.
3.
Zurück zum Zitat National Institute of Infectious Disease and Tuberculosis and Infectious Disease Control Division, Ministry of Health, Labour and Welfare. Measles and rubella in Japan, as of March 2006. Infect Agents Surveill Rep. 2007;28:239–73. National Institute of Infectious Disease and Tuberculosis and Infectious Disease Control Division, Ministry of Health, Labour and Welfare. Measles and rubella in Japan, as of March 2006. Infect Agents Surveill Rep. 2007;28:239–73.
4.
Zurück zum Zitat Nagai M, Xin JY, Yoshida N, Miyata A, Fujino M, Ihara T, Yoshikawa T, Asano Y, Nakayama T. Modified adult measles in outbreak in Japan, 2007–2008. J Med Virol. 2009;81:1094–101.PubMedCrossRef Nagai M, Xin JY, Yoshida N, Miyata A, Fujino M, Ihara T, Yoshikawa T, Asano Y, Nakayama T. Modified adult measles in outbreak in Japan, 2007–2008. J Med Virol. 2009;81:1094–101.PubMedCrossRef
5.
Zurück zum Zitat Nagano H, Jinushi M, Tanabe H, Yamaguchi R, Okano M. Epidemiological and molecular studies of measles at different clusters in Hokkaido Distinct, Japan, 2007. Jpn J Infect Dis. 2009;62:209–11.PubMedCrossRef Nagano H, Jinushi M, Tanabe H, Yamaguchi R, Okano M. Epidemiological and molecular studies of measles at different clusters in Hokkaido Distinct, Japan, 2007. Jpn J Infect Dis. 2009;62:209–11.PubMedCrossRef
6.
Zurück zum Zitat Kurata T, Miyagawa H, Furutani E, Kase T, Takahashi K. An outbreak of measles classified as genotype H1 in 2008 in Osaka Prefecture. Jpn J Infect Dis. 2009;62:76–7.PubMed Kurata T, Miyagawa H, Furutani E, Kase T, Takahashi K. An outbreak of measles classified as genotype H1 in 2008 in Osaka Prefecture. Jpn J Infect Dis. 2009;62:76–7.PubMed
7.
Zurück zum Zitat Morita Y, Suzuki T, Shiono M, Shiobara M, Saitoh M, Tsukagoshi H, et al. Sequence and phylogenetic analysis of nucleoprotein (N) gene in measles viruses prevent in Gunma, Japan, in 2007. Jpn J Infect Dis. 2007;60:402–4.PubMed Morita Y, Suzuki T, Shiono M, Shiobara M, Saitoh M, Tsukagoshi H, et al. Sequence and phylogenetic analysis of nucleoprotein (N) gene in measles viruses prevent in Gunma, Japan, in 2007. Jpn J Infect Dis. 2007;60:402–4.PubMed
8.
Zurück zum Zitat Ueda K, Miyazaki C, Hidaka Y, Okada K, Kusuhara R, Kadoya R. Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan. Lancet. 1995;346:701–2.PubMedCrossRef Ueda K, Miyazaki C, Hidaka Y, Okada K, Kusuhara R, Kadoya R. Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan. Lancet. 1995;346:701–2.PubMedCrossRef
9.
Zurück zum Zitat Neumann PW, Weber JM, Jessamine AG, O’Shaughnessy MV. Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay and hemagglutination inhibition test with neutralization test for determination of immune status. J Clin Microbiol. 1985;2:296–8. Neumann PW, Weber JM, Jessamine AG, O’Shaughnessy MV. Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay and hemagglutination inhibition test with neutralization test for determination of immune status. J Clin Microbiol. 1985;2:296–8.
10.
Zurück zum Zitat Chen RT, Markowitz LE, Albrecht P, Stewart JA, Mofenson LM, Preblud SR, Orenstein WA. Measles antibody: reevaluation of protective titers. J Infect Dis. 1990;162:1036–42.PubMedCrossRef Chen RT, Markowitz LE, Albrecht P, Stewart JA, Mofenson LM, Preblud SR, Orenstein WA. Measles antibody: reevaluation of protective titers. J Infect Dis. 1990;162:1036–42.PubMedCrossRef
11.
Zurück zum Zitat Linnemann CC, Rotte TC, Schiff GM. A seroepidemiologic study of a measles epidemic in a highly immunized population. Am J Epidemiol. 1972;95:238–46.PubMed Linnemann CC, Rotte TC, Schiff GM. A seroepidemiologic study of a measles epidemic in a highly immunized population. Am J Epidemiol. 1972;95:238–46.PubMed
12.
Zurück zum Zitat Krugman S. Further-attenuated measles vaccine: characteristic and use. Rev Infect Dis. 1983;5:477–81.PubMedCrossRef Krugman S. Further-attenuated measles vaccine: characteristic and use. Rev Infect Dis. 1983;5:477–81.PubMedCrossRef
13.
Zurück zum Zitat Orenstein WA, Herrmann KL, Albrecht P, Bernier R, Holmgreen O, Bart KJ, Hinman AR. Immunity against measles and rubella in Massachusetts schoolchildren. Dev Biol Stand. 1986;65:75–83.PubMed Orenstein WA, Herrmann KL, Albrecht P, Bernier R, Holmgreen O, Bart KJ, Hinman AR. Immunity against measles and rubella in Massachusetts schoolchildren. Dev Biol Stand. 1986;65:75–83.PubMed
14.
Zurück zum Zitat Forghani B, Schmidt NJ. Antigen requirements, sensitivity, and specificity of enzyme immunoassays for measles and rubella viral antibodies. J Clin Microbiol. 1979;9(6):657–64.PubMed Forghani B, Schmidt NJ. Antigen requirements, sensitivity, and specificity of enzyme immunoassays for measles and rubella viral antibodies. J Clin Microbiol. 1979;9(6):657–64.PubMed
15.
Zurück zum Zitat Boteler WL, Luipersbeck PM, Fuccillo DA, O’Beirne AJ. Enzyme-linked immunosorbent assay for detection of measles antibody. J Clin Microbiol. 1983;17(5):814–8.PubMed Boteler WL, Luipersbeck PM, Fuccillo DA, O’Beirne AJ. Enzyme-linked immunosorbent assay for detection of measles antibody. J Clin Microbiol. 1983;17(5):814–8.PubMed
16.
Zurück zum Zitat Weigle KA, Murphy MD, Brunell PA. Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus. J Clin Microbiol. 1984;19(3):376–9.PubMed Weigle KA, Murphy MD, Brunell PA. Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus. J Clin Microbiol. 1984;19(3):376–9.PubMed
17.
Zurück zum Zitat Neumann PW, Weber JM, Jessamine AG, O’Shaughnessy MV. Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status. J Clin Microbiol. 1985;22(2):296–8.PubMed Neumann PW, Weber JM, Jessamine AG, O’Shaughnessy MV. Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status. J Clin Microbiol. 1985;22(2):296–8.PubMed
18.
Zurück zum Zitat Souza VAUF, Pannuti CS, Sumita LM, Albrecht P. Enzyme-linked immunosorbent assay (ELISA) for measles antibody. A comparison with haemagglutination inhibition, immunofluorescence and plaque neutralization tests. Rev Inst Med Trop São Paulo. 1991;33(1):32–6.PubMedCrossRef Souza VAUF, Pannuti CS, Sumita LM, Albrecht P. Enzyme-linked immunosorbent assay (ELISA) for measles antibody. A comparison with haemagglutination inhibition, immunofluorescence and plaque neutralization tests. Rev Inst Med Trop São Paulo. 1991;33(1):32–6.PubMedCrossRef
19.
Zurück zum Zitat Cherry JD, Feigin RD, Lobes LA, Shackelford PG. Atypical measles in children previously immunized with attenuated measles virus vaccine. Pediatrics. 1972;50:712–7.PubMed Cherry JD, Feigin RD, Lobes LA, Shackelford PG. Atypical measles in children previously immunized with attenuated measles virus vaccine. Pediatrics. 1972;50:712–7.PubMed
20.
Zurück zum Zitat Smith FR, Curran AS, Raciti A, Black FL. Reported measles in persons immunologically primed by prior vaccination. J Pediatr. 1982;101:391–3.PubMedCrossRef Smith FR, Curran AS, Raciti A, Black FL. Reported measles in persons immunologically primed by prior vaccination. J Pediatr. 1982;101:391–3.PubMedCrossRef
21.
Zurück zum Zitat Wintermayer L, Myers MG. Measles in a partially immunized community. Am J Public Health. 1979;69:923–7.CrossRef Wintermayer L, Myers MG. Measles in a partially immunized community. Am J Public Health. 1979;69:923–7.CrossRef
22.
Zurück zum Zitat Mathias RC, Meekison WG, Arcand TA, Schecter MT. The role of secondary vaccine failures in measles outbreaks. Am J Public Health. 1989;79:475–8.PubMedCrossRef Mathias RC, Meekison WG, Arcand TA, Schecter MT. The role of secondary vaccine failures in measles outbreaks. Am J Public Health. 1989;79:475–8.PubMedCrossRef
23.
Zurück zum Zitat Frank JA, Orenstein WA, Bart KJ, Bart SW, EL-Tantawy N, Davis RM, Hinman AR. Major impediments to measles elimination: the modern epidemiology of an ancient disease. Am J Dis Child. 1985;139:881–8.PubMed Frank JA, Orenstein WA, Bart KJ, Bart SW, EL-Tantawy N, Davis RM, Hinman AR. Major impediments to measles elimination: the modern epidemiology of an ancient disease. Am J Dis Child. 1985;139:881–8.PubMed
24.
Zurück zum Zitat Schaffner W, Schluederberg AES, Byrne EB. Clinical epidemiology of sporadic measles in a highly immunized population. N Engl J Med. 1988;279:783–9.CrossRef Schaffner W, Schluederberg AES, Byrne EB. Clinical epidemiology of sporadic measles in a highly immunized population. N Engl J Med. 1988;279:783–9.CrossRef
Metadaten
Titel
A case study of measles vaccination for university students during the measles outbreak in Tokyo, Japan, 2007
verfasst von
Ryuichi Fujisaki
Mariko Yamamura
Shigeru Abe
Kousuke Shimogawara
Michihiro Kasahara
Hajime Nishiya
Miho Makimura
Koichi Makimura
Publikationsdatum
01.06.2012
Verlag
Springer Japan
Erschienen in
Journal of Infection and Chemotherapy / Ausgabe 3/2012
Print ISSN: 1341-321X
Elektronische ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-011-0343-x

Weitere Artikel der Ausgabe 3/2012

Journal of Infection and Chemotherapy 3/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.